Beta Bionics, Inc. (BBNX) Insider Trading

Over the last 3 months, BBNX insiders made 0 open-market buys and 14 sales, a net sale of -$767K (SEC Form 4). Over the last 6 months, 117 institutions increased and 78 reduced their position (13F).

Insider Activity

Sentiment
0/100
Buys (3m)
0
Sells (3m)
14
Net (3m)
-$766.6K
Insider trades by month Buys Sells
Nov
Dec
Jan
Mar
May
Jun
Context3-month price +56.4%Institutions accumulating (13F)
DateInsiderTypeSharesPrice
Jun 30, 2026Feider Stephenofficer: Chief Financial OfficerSell5,104$17.05
Jun 30, 2026Feider Stephenofficer: Chief Financial OfficerOption4,982$5.10
Jun 30, 2026Feider Stephenofficer: Chief Financial OfficerSell4,896$17.03
Jun 30, 2026Feider Stephenofficer: Chief Financial OfficerOption4,896$5.10
Jun 25, 2026Hopman Markofficer: Chief Commercial OfficerSell1,258$15.01
Jun 25, 2026Jones ChristydirectorSell1,406$15.00
Jun 5, 2026Hopman Markofficer: Chief Commercial OfficerSell275$12.31
Jun 5, 2026Jones ChristydirectorSell2,811$14.00
Jun 3, 2026Mensinger Mikeofficer: Chief Product OfficerSell4,378$12.61
Jun 3, 2026Russell Steven Jonofficer: Chief Medical OfficerSell4,222$12.61
Jun 3, 2026Feider Stephenofficer: Chief Financial OfficerSell6,676$12.61
Jun 3, 2026Saint Seandirector, officer: President & CEOSell16,872$12.61
Jun 3, 2026Hopman Markofficer: Chief Commercial OfficerSell5,329$12.61
May 26, 2026CARNEY SEANdirectorGrant16,965
May 26, 2026Palasis MariadirectorGrant16,965
May 26, 2026Jones ChristydirectorGrant16,965
May 26, 2026MICHEL GERARD JdirectorGrant16,965
May 26, 2026Jones ChristydirectorSell1,998$9.95
May 26, 2026Lezack AdamdirectorSell998$11.21
May 26, 2026Lezack AdamdirectorGrant16,965
May 26, 2026Lezack AdamdirectorSell1,000$9.95
May 26, 2026Dearen Danny L.directorGrant16,965
Mar 16, 2026Hopman Markofficer: Chief Commercial OfficerSell856$29.34
Mar 16, 2026Russell Steven Jonofficer: Chief Medical OfficerSell1,025$29.34
Mar 16, 2026Hopman Markofficer: Chief Commercial OfficerSell2,061$30.66
Mar 13, 2026Mensinger Mikeofficer: Chief Product OfficerGrant91,520$12.63
Mar 13, 2026Russell Steven Jonofficer: Chief Medical OfficerGrant91,520$12.63
Mar 13, 2026Feider Stephenofficer: Chief Financial OfficerGrant110,342$12.63
Mar 13, 2026Hopman Markofficer: Chief Commercial OfficerGrant91,520$12.63
Mar 13, 2026Saint Seandirector, officer: President & CEOGrant287,944$12.63

Source: BBNX SEC Form 4 filings, latest Jun 30, 2026. For informational purposes only — not investment advice.

Institutional activity (13F)

How institutions changed their BBNX positions over the last 6 months (SEC Form 13F).

Increased
117
New positions
64
Reduced
78
Sold out
62
Largest moves
InstitutionActionSharesFiled
EVENTIDE ASSET MANAGEMENT, LLCIncreased5.9MMay 15, 2026
EVENTIDE ASSET MANAGEMENT, LLCIncreased5.0MFeb 13, 2026
SOLEUS CAPITAL MANAGEMENT, L.P.Increased4.4MMay 14, 2026
FARALLON CAPITAL MANAGEMENT LLCUnchanged4.3MFeb 17, 2026
FARALLON CAPITAL MANAGEMENT LLCIncreased4.3MFeb 17, 2026
MORGAN STANLEYReduced4.2MMay 15, 2026
SANDS CAPITAL VENTURES, LLCIncreased3.7MMay 8, 2026
FARALLON CAPITAL MANAGEMENT LLCReduced3.6MMay 15, 2026
SANDS CAPITAL VENTURES, LLCUnchanged3.6MFeb 13, 2026
MORGAN STANLEYReduced3.5MFeb 13, 2026
VANGUARD CAPITAL MANAGEMENT LLCNew Position3.5MMay 15, 2026
BLACKROCK, INC.Increased3.0MMay 13, 2026
BLACKROCK, INC.Increased2.9MFeb 12, 2026
SOLEUS CAPITAL MANAGEMENT, L.P.Reduced2.5MFeb 12, 2026
POINT72 ASSET MANAGEMENT, L.P.Increased2.5MMay 15, 2026

Source: SEC Form 13F filings. For informational purposes only — not investment advice.